Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0LG4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,549
Award facts
- Contract value 100% obligated
- $32,548.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,548.58 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors (2 ml units) on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, regularly fulfills federal medical procurement needs through the DLA Medical Supply Chain with a diverse portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Dupixent is a biologic medication used to treat inflammatory conditions including eczema and asthma, reflecting the company's capability to deliver specialty pharmaceutical products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contract vehicles designed to meet complex medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F0LG4?
SPE2DR26F0LG4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F0LG4 worth?
The government has obligated $32,549 on SPE2DR26F0LG4.
Is contract SPE2DR26F0LG4 an order under another contract?
Yes. SPE2DR26F0LG4 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0LG4 competed?
The extent of competition for SPE2DR26F0LG4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award